Pharmaceutical Patent Analyst
Title Abbreviation
Pharm Pat Anal
Electronic ISSN
2046-8962
Readership
Bioengineers, Biologists, Biomedical Engineers/Technologists, Biomedical Researchers, Medicinal Chemists, Medicolegal Professionals, Pharmaco-Epidemiologists, Pharmacologists, Researchers, Scientists, Statisticians
Scope
Pharmaceutical Patent Analyst is dedicated to making the essential content of key patents available in a concise and enriched format to researchers and other specialists, while also providing timely commentary on important issues related to patent and IP law.
As one of the main drivers of innovation, in both academia and industry, patents are a rich source of technical information about the latest advances in the discovery and design of novel therapeutics and healthcare products.
The journal’s core content therefore comprises high-impact patent reviews that provide an objective and concise appraisal of selected patents in a chosen area, set within the context of the wider relevant R&D landscape. Articles exploring patenting trends as well as those examining new methodologies for searching the patent literature also feature.
Complementing the core scientific review content of each issue are news updates, editorials, interviews and hot topic articles presenting enlightened opinion and commentary on pressing IP issues related to the pharmaceutical patent life-cycle or to R&D more broadly.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Future Science Ltd.
To see more details about Pharmaceutical Patent Analyst,
Subscribe Now!
Impact Factor
JCR Categories/Rank
Electronic Circulation
Submission to Acceptance
Acceptance to Online Publication
Acceptance to Print Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines